76519-1170 NDC - BUPRENORPHINE HCL ()

Drug Information

Product NDC: 76519-1170

Proprietary Name: BUPRENORPHINE HCL

Non Proprietary Name:

Active Ingredient(s):


Administration Route(s):

Dosage Form(s):

Labeler Information

Labeler Name: H.J. Harkins Company, Inc.
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:3/16/2018

Package Information

No. Package Code Package Description Billing Unit
176519-1170-014 TABLET in 1 BOTTLE (76519-1170-0)
276519-1170-128 TABLET in 1 BOTTLE (76519-1170-1)
376519-1170-256 TABLET in 1 BOTTLE (76519-1170-2)
476519-1170-370 TABLET in 1 BOTTLE (76519-1170-3)
576519-1170-484 TABLET in 1 BOTTLE (76519-1170-4)
676519-1170-542 TABLET in 1 BOTTLE (76519-1170-5)

NDC Record

Field Name Field Value Definition
PRODUCT NDC76519-1170The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEBUPRENORPHINE HCLThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXSLA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
START MARKETING DATE3/16/2018This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEH.J. Harkins Company, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023